Table 3.
Univariate and multivariable Cox regression analysis on time to clinical relapse.
| Variable (per unit increase) | Clinical relapse HR (95% CI) | |
|---|---|---|
| Univariate | Multivariable | |
| Initial inhibitor level | 1.16 (0.94, 1.44), p-value: 0.17 | 1.23 (0.97, 1.56), p-value: 0.084* |
| Nadir platelet count | 0.98 (0.90, 1.06), p-value: 0.60 | |
| Initial ANC | 0.79 (0.65, 0.98), p-value: 0.029 | 0.74 (0.58, 0.96), p-value: 0.020 |
| Initial serum creatinine | 1.36 (1.02, 1.82), p-value: 0.035 | 1.42 (1.03, 1.94), p-value: 0.032 |
Controlled for type of therapy only. All the other analyses controlled for all the baseline characteristics listed in Table 1.